标题
Pazopanib: a promising new agent in the treatment of soft tissue sarcomas
作者
关键词
-
出版物
Future Oncology
Volume 7, Issue 12, Pages 1373-1383
出版商
Future Medicine Ltd
发表日期
2011-11-23
DOI
10.2217/fon.11.116
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pazopanib for the treatment of renal cancer
- (2011) Brian Rini et al. EXPERT OPINION ON PHARMACOTHERAPY
- Testing new regimens in patients with advanced soft tissue sarcoma: analysis of publications from the last 10 years
- (2010) N. Penel et al. ANNALS OF ONCOLOGY
- Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism
- (2010) C-F Xu et al. BRITISH JOURNAL OF CANCER
- Pazopanib: a multikinase inhibitor with activity in advanced renal cell carcinoma
- (2010) Ronald M Bukowski Expert Review of Anticancer Therapy
- Comparison of Two Doses of Imatinib for the Treatment of Unresectable or Metastatic Gastrointestinal Stromal Tumors: A Meta-Analysis of 1,640 Patients
- (2010) JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206
- (2010) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
- (2010) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Association of the hemochromatosis gene with pazopanib-induced transaminase elevation in renal cell carcinoma
- (2010) Chun-Fang Xu et al. JOURNAL OF HEPATOLOGY
- (Pre-)Clinical Pharmacology and Activity of Pazopanib, a Novel Multikinase Angiogenesis Inhibitor
- (2010) P. Hamberg et al. ONCOLOGIST
- Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?
- (2009) Kristy J. Gotink et al. ANGIOGENESIS
- Phase I Trial of Pazopanib in Patients with Advanced Cancer
- (2009) H. I. Hurwitz et al. CLINICAL CANCER RESEARCH
- New medical treatment options and strategies to assess clinical outcome in soft-tissue sarcoma
- (2009) Thomas Schmitt et al. Expert Review of Anticancer Therapy
- Absence of Progression As Assessed by Response Evaluation Criteria in Solid Tumors Predicts Survival in Advanced GI Stromal Tumors Treated With Imatinib Mesylate: The Intergroup EORTC-ISG-AGITG Phase III Trial
- (2009) Axel Le Cesne et al. JOURNAL OF CLINICAL ONCOLOGY
- Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)
- (2009) Stefan Sleijfer et al. JOURNAL OF CLINICAL ONCOLOGY
- Paclitaxel in patients with advanced angiosarcomas of soft tissue: A retrospective study of the EORTC soft tissue and bone sarcoma group
- (2008) M. Schlemmer et al. EUROPEAN JOURNAL OF CANCER
- Discovery of 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor†
- (2008) Philip A. Harris et al. JOURNAL OF MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now